Analysis of Human Tear Proteins in Children

The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film, and any unique aspects of tears in children. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Eye Disease Eye Diseases

Age range

Up to 17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The Childrens Hospital

Denver, Colorado, 80218, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Less than 18 years of age
A parent or legal guardian provide written informed consent to participate
Able to cooperate with tear sample collection, or a previously planned sedation for other medical purposes

Exclusion criteria

Age greater than or equal to 18 years
Patients' parents or legal guardians who refuse to sign study consent

Treatment and study plan

Primary outcomes

Proteome of Human Tears

Time frame: Single Exam

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Registry information

Official study title

Analysis of Human Tear Proteins in Children: A Pilot Study to Describe the Tear Film Proteome of Pediatric Patients Undergoing Ophthalmic Examination.

Important dates

Study start: 2007
Primary completion: 2009
Study completion: 2009
First posted: May 15, 2007
Registry last updated: Jan 30, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed